Personalized chemotherapy in clear cell adenocarcinoma of the urethra: A case report

doi:10.5306/wjco.v11.i4.243

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6616)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

353

WORD

121

HTML

4013

Figures (1-2)

314

Sum=4801

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

746

Download

1069

Sum=1815

Apr 24, 2020 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Apr 24, 2020; 11(4): 243-249
Published online Apr 24, 2020. doi: 10.5306/wjco.v11.i4.243

Full Size Figure Download Figure

Figure 2 Positron emission tomography scan. A: Prior to non-platinum-based chemotherapy consisting of paclitaxel/bevacizumab; B: Following 3 cycles of this combination chemotherapy; C: After 6 cycles of this combination chemotherapy.

Citation: Shields LBE, Kalebasty AR. Personalized chemotherapy in clear cell adenocarcinoma of the urethra: A case report. World J Clin Oncol 2020; 11(4): 243-249
URL: https://www.wjgnet.com/2218-4333/full/v11/i4/243.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i4.243